Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 4/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.47 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | APEX1 | P27695 | 1/20 | 0.44 |
| ▸ | GMNN | O75496 | 1/20 | 0.44 |
| ▸ | TFPI2 | P48307 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
| ▸ | THPO | P40225 | 1/20 | 0.44 |
| ▸ | GRM2 | Q14416 | 3/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL66048 | 1.00 | POLB (0.47) | POLBTDP1CTDSP1TSHRLMNA | |
| SCHEMBL1963633 | 1.00 | POLB (0.47) | POLBTDP1CTDSP1TSHRLMNA | |
| SCHEMBL9782982 | 1.00 | POLB (0.47) | POLBTDP1CTDSP1TSHRLMNA | |
| SCHEMBL9271352 | 1.00 | POLB (0.47) | POLBTDP1CTDSP1TSHRLMNA | |
| SCHEMBL9782992 | 1.00 | POLB (0.47) | POLBTDP1CTDSP1TSHRLMNA | |
| SCHEMBL9782989 | 1.00 | POLB (0.47) | POLBTDP1CTDSP1TSHRLMNA | |
| SCHEMBL676573 | 1.00 | POLB (0.47) | POLBTDP1CTDSP1TSHRLMNA | |
| SCHEMBL9782996 | 1.00 | POLB (0.47) | POLBTDP1CTDSP1TSHRLMNA | |
| SCHEMBL9782987 | 1.00 | POLB (0.47) | POLBTDP1CTDSP1TSHRLMNA | |
| SCHEMBL911207 | 1.00 | POLB (0.47) | POLBTDP1CTDSP1TSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 619 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12538727-B2 | Treatment liquid for semiconductor with ruthenium | TOKUYAMA CORPORATION (JP) | 2026-01-27 | — | — | US | claimed |
| CN-119683824-A | Hard scale reduction method for coal gasification black water | 安徽碳鑫科技有限公司 | 2025-03-25 | — | — | CN | claimed |
| US-20240180157-A1 | LAUNDERABLE BACTERICIDAL AND VIRUCIDAL FABRIC FINISH | NANO AND ADVANCED MATERIALS INSTITUTE LIMITED (HK) | 2024-06-06 | — | — | US | claimed |
| CN-114940755-B | Polyamide elastomer and preparation method thereof | 华润化学材料科技股份有限公司 | 2024-03-01 | — | — | CN | claimed |
| US-20240052099-A1 | POLYANHYDRIDES AND METHODS OF MAKING SAME | POLYGENE LTD. (IL) | 2024-02-15 | — | — | US | claimed |
| US-11856953-B2 | Launderable bactericidal and virucidal fabric finish | NANO AND ADVANCED MATERIALS INSTITUTE LIMITED (HK) | 2024-01-02 | — | — | US | claimed |
| CN-117089082-A | Preparation method of iron-based metal organic framework material | 北京建筑大学 | 2023-11-21 | — | — | CN | claimed |
| CN-116419764-A | Polyanhydride and preparation method thereof | 多基因有限公司 | 2023-07-11 | — | — | CN | claimed |
| US-20230207329-A1 | TREATMENT LIQUID FOR SEMICONDUCTOR WITH RUTHENIUM | TOKUYAMA CORPORATION (JP) | 2023-06-29 | — | — | US | claimed |
| EP-4192905-A1 | POLYANHYDRIDES AND METHODS OF MAKING SAME | Polygene Ltd. (IL) | 2023-06-14 | — | — | EP | claimed |
| US-7033424-B2 | Phase change inks | XEROX CORPORATION (US) | 2006-04-25 | — | — | US | claimed |
| US-7018422-B2 | Shrink resistant and wrinkle free textiles | STRIKE INVESTMENTS, LLC | 2006-03-28 | — | — | US | claimed |
| US-7008457-B2 | Textile finishing composition and methods for using same | STRIKE INVESTMENTS, LLC | 2006-03-07 | — | — | US | claimed |
| US-20060021546-A1 | Processes for preparing phase change inks | XEROX CORPORATION | 2006-02-02 | — | — | US | claimed |
| US-20060016369-A1 | PHASE CHANGE INKS | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-20060020141-A1 | Metallized dye | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-6989035-B2 | Textile finishing composition and methods for using same | THE PROCTER & GAMBLE COMPANY (US) | 2006-01-24 | — | — | US | claimed |
| US-20030092598-A1 | Shrink resistant and wrinkle free textiles | THE PROCTER & GAMBLE COMPANY | 2003-05-15 | — | — | US | claimed |
| US-20030087757-A1 | Image-recording composition and image-recording sheet using same | ASAHI KOGAKU KOGYO KABUSHIKI KAISHA (JP) | 2003-05-08 | — | — | US | claimed |
| US-4188372-A | Antibacterial oral composition | COLGATE-PALMOLIVE COMPANY (US) | 1980-02-12 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11856953-B2 | Launderable bactericidal and virucidal fabric finish | LBR, B2M, LPO | POLB 76/4885TDP1 1334/4885CTDSP1 2110/4885 |
| US-12538727-B2 | Treatment liquid for semiconductor with ruthenium | ROS1, HAO2, SCO2 | POLB 1041/4885TDP1 3617/4885CTDSP1 1914/4885 |
| US-20240180157-A1 | LAUNDERABLE BACTERICIDAL AND VIRUCIDAL FABRIC FINISH | LBR, B2M, LPO | POLB 86/4885TDP1 1332/4885CTDSP1 2105/4885 |
| US-20060020141-A1 | Metallized dye | CDYL, CDY1; CDY1B, CDYL2 | POLB 1788/4885TDP1 3338/4885CTDSP1 3748/4885 |
| US-20240052099-A1 | POLYANHYDRIDES AND METHODS OF MAKING SAME | PUF60, DDOST, PARG | POLB 1387/4885TDP1 1935/4885CTDSP1 1258/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.